FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to experimental pharmacology, dermatology, surgery, and can be used for treating long-term non-healed scalp infected wounds requiring pharmacological correction (stimulation) of immunity and reparative processes. Method is achieved by using pharmacological agents, characterized in that a synthetic low-molecular immunomodulator of peptide nature is prescribed – preparation Moliksan® subcutaneously in dose of 30 mg/kg to experimental animals daily one time throughout the period of antibacterial therapy with levoflocacine 21 mg/kg. Disclosed is a method for pharmacological correction of post-traumatic disorders of immunity and reparative processes in mammals.
EFFECT: invention extends the range of methods for pharmacological correction of immunity and reparative processes.
1 cl, 6 tbl
Title | Year | Author | Number |
---|---|---|---|
BACTERICIDAL PHARMACEUTICAL COMPOSITION FOR TOPICAL APPLICATION IN THE FORM OF AN ENDOLYSIN-CONTAINING BACTERICIDAL GEL | 2021 |
|
RU2781050C1 |
NIOSOMAL ANTIMICROBIAL GEL FOR TREATING DIABETIC ULCERS, WOUNDS, BURNS, INCLUDING THOSE INFECTED WITH ANTIBIOTIC-RESISTANT MICROORGANISMS | 2021 |
|
RU2781402C2 |
METHOD FOR PREVENTION AND TREATMENT OF DANGEROUS NEUROVIRAL INFECTIONS | 2016 |
|
RU2642312C1 |
TREATMENT METHOD OF CHRONICALLY NON-HEALING WOUNDS | 2016 |
|
RU2620336C1 |
AGENT STIMULATING REPARATIVE PROCESSES AND METHOD OF ITS USE | 1998 |
|
RU2139085C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING GYNAECOLOGICAL DISEASES IN COWS AND PIGS | 2021 |
|
RU2776925C1 |
PHARMACEUTICAL COMBINED COMPOSITION FOR THE TREATMENT OF PURULENT WOUNDS ON THE BASIS OF FLUOROQUINOLONS (OPTIONS) | 2016 |
|
RU2682171C2 |
METHOD OF TREATING HARD-HEALING WOUNDS IN EXPERIMENT | 2019 |
|
RU2715145C1 |
METHOD FOR PROTECTION AGAINST CORONAVIRUS INFECTION | 2020 |
|
RU2747467C1 |
ANTI-BURN AGENT | 2019 |
|
RU2703295C1 |
Authors
Dates
2019-08-30—Published
2018-12-28—Filed